![Linda Rubinstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Linda Rubinstein
Finanzdirektor/CFO bei
NEKTAR THERAPEUTICS
Profil
Linda M.
Rubinstein is Chief Financial & Accounting Officer at Nektar Therapeutics since 2026.
Ms. Rubinstein is Partner at FLG Partners LLC since 2010.
Former roles include Independent Director at Biocept, Inc. from 2021 to 2023; Chief Accounting Officer at Alector, Inc. in 2022; Chief Financial & Accounting Officer at Adverum Biotechnologies, Inc. from 2022 to 2025; Chief Financial Officer at Apexigen, Inc. from 2018 to 2022; Chief Financial & Accounting Officer at Five Prime Therapeutics, Inc. in 2018; Chief Financial Officer at ArmaGen, Inc. from 2015 to 2020; Chief Financial Officer & Executive Vice President at Emergent Travel Health, Inc. in 2014; Director at Sensor Innovations, Inc. from 2007 to 2015; Chief Financial Officer at Solexa, Inc. from 2005 to 2007; Chief Financial Officer & Senior Vice President at Ingenuity Systems, Inc.; Chief Financial Officer at RenovoRx, Inc.; Chief Financial Officer at iPierian, Inc.; Senior Banker at Lehman Brothers, Inc.; Principal at Merrill Lynch Capital Partners, Inc.; and Chief Financial Officer at iPierian, Inc. Education includes undergraduate and graduate degrees from the University of California, Los Angeles.
Aktive Positionen von Linda Rubinstein
| Unternehmen | Position | Beginn |
|---|---|---|
| NEKTAR THERAPEUTICS | Finanzdirektor/CFO | 15.05.2026 |
FLG Partners LLC
 FLG Partners LLC Miscellaneous Commercial ServicesCommercial Services Operates consulting and board advisory company | Corporate Officer/Principal | 01.09.2010 |
Ehemalige bekannte Positionen von Linda Rubinstein
| Unternehmen | Position | Ende |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Finanzdirektor/CFO | 09.12.2025 |
| BIOCEPT, INC. | Direktor/Vorstandsmitglied | 13.10.2023 |
| APEXIGEN, INC. | Finanzdirektor/CFO | 10.06.2022 |
| ALECTOR, INC. | Finanzdirektor/CFO | 07.02.2022 |
ArmaGen, Inc.
 ArmaGen, Inc. Pharmaceuticals: MajorHealth Technology Develops neurological therapies | Finanzdirektor/CFO | 01.04.2020 |
Ausbildung von Linda Rubinstein
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
65
Beziehungen ersten Grades
17
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 17 |
|---|---|
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Nektar Therapeutics
 Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
Biocept, Inc.
 Biocept, Inc. Medical/Nursing ServicesHealth Services Develops and performs clinical laboratory tests to detection & analysis of tumor cells and cell-free DNA from cerebrospinal fluid | Health Services |
Five Prime Therapeutics, Inc.
 Five Prime Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops protein therapeutics for cancer and inflammatory diseases | Health Technology |
Ingenuity Systems, Inc.
 Ingenuity Systems, Inc. Information Technology ServicesTechnology Services Provides information solutions for life science researchers | Technology Services |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. Commercial Printing/FormsCommercial Services Provides vital travel health information services | Commercial Services |
Sensor Innovations, Inc.
 Sensor Innovations, Inc. BiotechnologyHealth Technology Develops and commercializes a novel, proprietary and versatile sensing technology platform | Health Technology |
ArmaGen, Inc.
ArmaGen, Inc. Pharmaceuticals: MajorHealth Technology Develops neurological therapies | Health Technology |
RenovoRx, Inc.
 RenovoRx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops therapies for the local treatment of solid tumors | Health Technology |
Merrill Lynch Capital Partners, Inc.
 Merrill Lynch Capital Partners, Inc. Investment Banks/BrokersFinance Security brokers & dealers | Finance |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solexa, Inc.
 Solexa, Inc. Pharmaceuticals: OtherHealth Technology Creates DNA cloning and analyses technologies | Health Technology |
iPierian, Inc.
 iPierian, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
FLG Partners LLC
FLG Partners LLC Miscellaneous Commercial ServicesCommercial Services Operates consulting and board advisory company | Commercial Services |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
Alector, Inc.
 Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
Apexigen, Inc.
 Apexigen, Inc. BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancer | Health Technology |
